Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
3.070
-0.270 (-8.08%)
At close: Nov 18, 2025, 4:00 PM EST
3.270
+0.200 (6.51%)
After-hours: Nov 18, 2025, 5:02 PM EST

Clearside Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-26-34.35-32.49-32.950.38-18.21
Upgrade
Depreciation & Amortization
0.330.230.070.150.180.18
Upgrade
Other Amortization
-----0.13
Upgrade
Loss (Gain) From Sale of Assets
---0.03--
Upgrade
Stock-Based Compensation
3.334.514.24.885.053.6
Upgrade
Other Operating Activities
2.976.599.363.28-10.06
Upgrade
Change in Accounts Payable
-2.34-1.430.610.690.68-0.63
Upgrade
Change in Unearned Revenue
--0.08-0.130.21-5-
Upgrade
Change in Other Net Operating Assets
0.42-0.170.2410.34-11.021.75
Upgrade
Operating Cash Flow
-21.29-24.7-18.14-13.37-10.73-13.12
Upgrade
Capital Expenditures
-0.45-0.98-1.78-0.25--0.06
Upgrade
Investment in Securities
9.750.34----
Upgrade
Investing Cash Flow
9.3-0.64-1.78-0.25--0.06
Upgrade
Long-Term Debt Issued
-----0.99
Upgrade
Long-Term Debt Repaid
------5.34
Upgrade
Net Debt Issued (Repaid)
------4.35
Upgrade
Issuance of Common Stock
3.5116.441.760.723.7812.22
Upgrade
Other Financing Activities
1.4--1.3530.64--
Upgrade
Financing Cash Flow
4.9116.440.4131.3323.787.87
Upgrade
Net Cash Flow
-7.09-8.9-19.517.7213.05-5.31
Upgrade
Free Cash Flow
-21.75-25.68-19.91-13.61-10.73-13.18
Upgrade
Free Cash Flow Margin
-653.23%-1542.97%-242.06%-1025.70%-36.29%-166.90%
Upgrade
Free Cash Flow Per Share
-4.22-5.22-4.83-3.39-2.69-4.25
Upgrade
Cash Interest Paid
-----0.52
Upgrade
Levered Free Cash Flow
-19.34-22.48-17.93-4.49-10.35-6.4
Upgrade
Unlevered Free Cash Flow
-12.72-16.37-12.08-2.4-10.35-6.32
Upgrade
Change in Working Capital
-1.92-1.680.7211.24-15.341.12
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q